Inhibitory activity of marine sponge-derived natural products against parasitic protozoa

Marine Drugs

Volumn 8, Issue 1, 2010, Pages 47-58

  Orhan, Ilkay ^a   Şener, Bilge ^a   Kaiser, Marcel ^b   Brun, Reto ^b   Tasdemir, Deniz ^c  

^a GAZI UNIVERSITY   (Turkey)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antiprotozoal activity; Ircinia; Leishmania; Marine sponge; Plasmodium; Spongia; Trypanosoma

Indexed keywords

11BETA ACETOXYSPONGI 12 EN 16 ONE; 12 EPI DEXOSCALARIN; 2 (HEXAPRENYLMETHYL) 2 METHYLCHROMENOL; 4 HYDROXY 3 OCTAPRENYLBENZOIC ACID; 4 HYDROXY 3 TETRAPRENYL PHENYLACETIC ACID; ANTILEISHMANIAL AGENT; ANTIMALARIAL AGENT; ANTITRYPANOSOMAL AGENT; DEMETHYLFUROSPONGIN 4; DORISENONE D; FUROSPINULOSIN 1; FUROSPINULOSIN 2; FUROSPONGIN 1; FUROSPONGIN 4; HEPTAPRENYL PENTO QUINOL; SQUALENE; TERPENOID DERIVATIVE; TRYPTOPHOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; IC 50; IN VITRO STUDY; LEISHMANIA DONOVANI; MAMMAL CELL; NONHUMAN; PLASMODIUM FALCIPARUM; RAT; SPONGE (PORIFERA); TRYPANOSOMA CRUZI; TRYPANOSOMA RHODESIENSE;

IRCINIA; LEISHMANIA DONOVANI; MAMMALIA; PLASMODIUM FALCIPARUM; PROTOZOA; SPONGIA; TRYPANOSOMA; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMA CRUZI;

EID: 76149101983     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md8010047     Document Type: Article

References (34)

1. WHO. World malaria report. World Health Organization, 2008. Available online http://malaria.who.int/ wmr2008/malaria2008.pdf (Accessed on 20 November 2009).
2. D'Alessandro, U. Existing antimalarial agents and malaria-treatment strategies. Exp. Opin. Pharmacother. 2009, 10, 1291-1306.
3. Wongsrichanalai, C.; Meshnick, S.R. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg. Infect. Dis. 2008, 14, 716-719.
4. Stuart, K.; Brun, R.; Croft, S.; Fairlamb, A.; Gürtler, R.E.; McKerrow, J.; Reed, S.; Tarleton, R. Kinetoplastids: related protozoan pathogens, different diseases. J. Clin. Invest. 2008, 118, 1301-1310.
5. Brun, R.; Blum, J.; Chappuis, F.; Burri, C. Human African trypanosomiasis. Lancet 2009, in press.
6. Bañuls, A.L.; Hide, M.; Prugnolle, F. Leishmania and the leishmaniasis: A parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv. Parasitol. 2007, 64, 1-109.
7. Mayer, A.M.S.; Hamann M.T. Marine pharmacology in 2001-2002: Marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C: Pharmacol. Toxicol. 2002, 140, 265-286.
8. Donia, M.; Hamann, M.T. Marine natural products and their potential applications as anti-infective agents. Lancet-Infec. Dis. 2003, 3, 338-348.
9. Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Hamann, M.T. Marine pharmacology in 2003-4: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C: Pharmacol. Toxicol. 2007, 145, 553-581.
10. Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Hamann, M.T. Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action. Biochim. Biophys. Acta 2009, 1790, 283-308.
11. Tasdemir, D.; Topaloglu, B.; Perozzo, R.; Brun, R.; O'Neill, R.; Carballeira, N.M.; Zhang, X.; Tonge, P.J.; Linden, A.; Rüedi, P. Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli. Bioorg. Med. Chem. 2007, 15, 6834-6845.
12. Del Rayo Camacho-Corona, M.; Croft, S.L.; Phillipson, J.D. Natural products as sources of antiprotozoal drugs. Curr. Op. Anti-inf. Invest. Drugs 2000, 2, 47-62.
13. Salem, M.M.; Werbovetz, K.A. Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis. Curr. Med. Chem. 2006, 13, 2571-2598.
14. De Rosa, S.; Mitova, M. Bioactive marine sesterterpenoids. In Studies in Natural Products Chemistry; Rahman, A.-ur, Ed.; Elsevier Science Publishers: Amsterdam, Netherlands, 2005; Vol. 32, pp.109-168.
15. Gochfeld, D.J.; Hamann, M.T. Isolation and biological evaluation of filiformin, plakortide F, and plakortone G from the Caribbean sponge Plakortis sp. J. Nat. Prod. 2001, 64, 1477-1479.
16. Benoit-Vical, F.; Salery, M.; Soh, P.N.; Ahond, A.; Poupat, C. Girolline: A potential lead structure for antiplasmodial drug research. Planta Med. 2008, 74, 438-444.
17. Desoubzdanne, D.; Marcourt, L.; Raux, R.; Chevalley, S.; Dorin, D.; Doerig, C.; Valentin, A.; Ausseil, F.; Debitus, C. Alisiaquinones and alisiaquinol, dual inhibitors of Plasmodium falciparum enzyme targets from a new Caledonian deep water sponge. J. Nat. Prod. 2008, 71, 1189-1192.
18. Casapullo, A.; Minale, L.; Zollo, F. Paniceins and related sesquiterpenoids from the Mediterranean sponge Reniera fulva. J. Nat. Prod. 1993, 56, 527-533.
19. Urios, A.; Largeron, M.; Fleury, M.B.; Blanco, M. A convenient approach for evaluating the toxicity profiles of in vitro neuroprotective alkylaminophenol derivatives. Free Rad. Biol. Med. 2006, 40, 791-800.
20. Gonzalez, M.A. Spongian diterpenes. Curr. Bioact. Compds. 2007, 3, 1-36.
21. Schmitz, F.J.; Chang, J.S.; Hossain, M.B.; Van der Helm, D. Marine natural products: Spongiane derivatives from the sponge Igernella notabilis. J. Org. Chem. 1985, 50, 2862-2865.
22. Vik, A.; Proszenyák, A.; Vermeersch, M.; Cos, P.; Maes, L.; Gundersen, L.L. Screening of agelasine D and analogs for inhibitory activity against pathogenic protozoa; identification of hits for visceral leishmaniasis and Chagas disease. Molecules 2009, 14, 279-288.
23. Akendengue, B.; Ngou-Milama, E.; Laurens, A.; Hocquemiller, R. Recent advances in the fight against leishmaniasis with natural products. Parasites 1999, 6, 3-8.
24. Staerk, D.; Lemmich, E.; Christensen, J.; Kharazmi, A.; Olsen, C.E.; Jaroszewski, J.W. Leishmanicidal, antiplasmodial and cytotoxic activity of indole alkaloids from Corynanthe pachyceras. Planta Med. 2000, 66, 531-536.
25. Fournet, A.; Munoz, V. Natural products as trypanocidal, antileishmanial and antimalarial drugs. Curr. Top Med. Chem. 2002, 2, 1215-1237.
26. Mishra, B.B.; Singh, R.K.; Srivastava, A.; Tripathi, V.S.; Tiwari, V.K. Fighting against leishmaniasis: Search of alkaloids as future true potential anti-leishmanial agents. Mini Rev. Med. Chem. 2009, 9, 107-123.
27. Erdogan, I.; Şener, B.; Higa, T. Tryptophol, a plant auxin isolated from the marine sponge Ircinia spinulosa. Biochem. System. Ecol. 2000, 28, 793-794.
28. Erdogan, I.; Tanaka, J.; Higa, T.; Şener, B. Terpenoids from two sponge species of the Aegean Sea. Nat. Prod. Sci. 1999, 5, 177-180.
29. Matile, H.; Pink, J.R.L. Plasmodium falciparum malaria parasite cultures and their use in immunology. In Immunological Methods; Lefkovits, I., Pernis, B., Eds.; Academic Press: San Diego, CA, USA, 1990; pp. 221-234.
30. Baltz, T.; Baltz, D.; Giroud, C.; Crockett, J. Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J. 1985, 4, 1273-1277.
31. Thuita, J.K.; Karanja, S.M.; Wenzler, T.; Mdachi, R.E.; Ngotho, J.M.; Kagira, J.M.; Tidwell, R.; Brun, R. Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis. Acta Trop. 2008, 108, 6-10.
32. Räz, B.; Iten, M.; Grether-Bühler, Y.; Kaminsky, R.; Brun, R. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense). Acta Trop. 1997, 68, 139-147.
33. Buckner, F.S.; Verlinde, C.L.; La Flamme, A.C.; van Voorhis, W.C. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing betagalactosidase. Antimicrob. Agents Chemother. 1996, 40, 2592-2597.
34. Mikus, J.; Steverding, D. A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. Parasitol. Int. 2000, 48, 265-269.